FDA NDC Directory · JSON-LD · Markdown

Montelukast Sodium

NDC 57237-213 · HUMAN PRESCRIPTION DRUG · TABLET, CHEWABLE

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202096
Dosage form / routeTABLET, CHEWABLE · ORAL
Active ingredientsMONTELUKAST SODIUM (5 mg/1)
Marketing started20120803
Package count2

External sources

Source: openFDA. Public-domain (CC0).